IBI343 in Combination With Sintilimab and SOX Regimen for Perioperative Treatment of Resectable, Locally Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Clinical trial NCT07483567 · RECRUITING
Trial details
- NCT number
- NCT07483567
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-17
- Primary completion
- 2030-06-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.